Kent E. Lieginger is listed as a director on 2 SEC Form D filings by 1 issuer between Jun 2016 and May 2017: Achaogen Inc (South San Francisco, CA — biotechnology — 2016–2017; $35.4M reported sold to 15 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alan Colowick (2 shared filings), Blake Wise (2 shared filings), Bryan Roberts (2 shared filings), Gregory Stea (2 shared filings), John C. Doyle (2 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Kent. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Kent E. Lieginger and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Kent E. Lieginger is written 2 different ways on the filings.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.